Initial metastatic kinetics is the best prognostic indicator in stage IV metastatic melanoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference15 articles.
1. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K;Villanueva;Cancer Cell,2010
2. Ipilimumab in advanced melanoma: reports of long-lasting responses;Farolfi;Melanoma Res,2012
3. Ipilimumab produces durable objective responses in patients with previously treated, Advanced melanoma: results from a phase III trial;Ottensmeier;Ann Oncol,2010
4. Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use;Ascierto;J Transl Med,2012
5. Which drug, and when, for patients with BRAF-mutant melanoma?;Jang;Lancet Oncol,2013
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy;European Journal of Cancer;2024-01
2. Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma;British Journal of Cancer;2021-07-14
3. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study;Journal for ImmunoTherapy of Cancer;2021-05
4. MOLECULAR LANDSCAPE OF OLD AGE MELANOMA BY SURVIVAL AND IMMUNOTHERAPY RESPONSE;2021-01-27
5. The Changing Kinetics of Advanced Melanoma;JAMA Dermatology;2019-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3